Jump to content

Home

DUKEHealth JA

Open menu
Cart
  • DUKEHealth JA login
  • Home
  • About Us
  • Activity Application
    • Activity Requirements
    • Credit Offered by Learner Type
    • Disclosure Form
  • Help Center
    • Course Admin Resources
    • Duke CE RSS Recordings
    • Learner Resources
    • Maintenance of Certification (MOC)
    • CE Logos
  • Contact Us
  • My Transcript

You are here

Home

Hematologic Malignancies Grand Rounds - FY19

Sessions

Session Date
Maximizing the Potential of Targeted Therapies within the Stem Cell Niche 11/08/2019 - 9:15am to 10:15am EST
Patient Preferences for Treatment Outcomes: Bringing the Patient Voice into Cancer Care Delivery and Research 11/15/2019 - 9:15am to 10:15am EST
Novel Agents Beyond JAKi in Treatment of patients with MPNs 11/22/2019 - 9:15am to 10:15am EST
Hematologic Malignancies Grand Rounds - FY19 11/29/2019 - 9:15am to 10:15am EST
Hematologic Malignancies Grand Rounds - FY19 12/06/2019 - 9:15am to 10:15am EST
Role of Proteasome Inhibition in the Treatment of Acute Myeloid Leukemia 12/13/2019 - 9:15am to 10:15am EST
Leah Is Four Years Old 12/20/2019 - 9:15am to 10:15am EST
Hematologic Malignancies Grand Rounds - FY19 12/27/2019 - 9:15am to 10:15am EST

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8

Features

  • Home
  • Sessions

 © 2026 Duke University Health System Disclaimer Duke & Your Privacy

Powered by the EthosCE Learning Management System, a continuing education LMS.
    • Home
    • About Us
    • Activity Application
      • Activity Requirements
      • Credit Offered by Learner Type
      • Disclosure Form
    • Help Center
      • Course Admin Resources
      • Duke CE RSS Recordings
      • Learner Resources
      • Maintenance of Certification (MOC)
      • CE Logos
    • Contact Us
    • My Transcript